NYT: Learning to Rewrite the Code of Life

The same technology that allows medical researchers to tinker with human cells is letting agricultural scientists alter crop genes. When the first wave of CRISPR studies came out, Catherine Feuillet, an expert on wheat, who was then at the French National Institute for Agricultural Research, immediately saw its potential for her own work… At Inari Agriculture, a company in Cambridge, Dr. Feuillet is overseeing efforts to use CRISPR to make breeds of soybeans and other crops that use less water and fertilizer.

Read full article at The New York Times.

RELATED POSTS

Inari Named One of TIME’s America’s Top GreenTech Companies 2026

Inari was recognized today on TIME’s list of America’s Top GreenTech Companies 2026. Presented by TIME and Statista, the leading statistics portal and industry ranking provider, the list recognizes 250…

READ MORE

Inari Featured in ‘Unseen Upside’ Podcast on AI in Agriculture

Inari Chief Scientific Officer Catherine Feuillet and Lucas Mann of Inari investor Acre Venture Partners are featured in the latest episode of the Unseen Upside podcast, spotlighting our AI-enabled SEEDesign™…

READ MORE

Inari Repeats as AgTech Company of the Year

For the fourth time in as many years, AgTech Breakthrough has named Inari the Overall AgTech Company of the Year.  The AgTech Breakthrough program strives to honor and represent the…

READ MORE